Tharimmune appoints Nancy Davis to board of directors

Canton Strategic Holdings, Inc.

Nancy Davis, founder of Race to Erase MS and Cure Addiction Now, joins Tharimmune board effective August 4, 2025.
Davis brings patient advocacy expertise and has raised over $56M for MS research through her foundation.
Her appointment aligns with Tharimmune's focus on TH104 for opioid countermeasures and broader pipeline.
Davis will serve until the 2026 annual meeting, with compensation consistent with other non-employee directors.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.